The US FDA has given the green light to 20 varieties of Philip Morris ZYN nicotine pouches, classifying them as modified risk products. This allows them to be marketed with the warning that they reduce certain risks of serious diseases compared to cigarettes. The measure aims to encourage adult smokers to consider less harmful options, although the health authority insists that no tobacco product is safe and requires vigilance to prevent their use among young people.
The technical development behind the FDA authorization 🧪
The approval is based on studies showing that ZYN pouches eliminate combustion, the main source of carcinogens in tobacco smoke. Philip Morris presented data on reduced exposure to harmful substances in adults who completely switch to the product. The FDA assessed the risks of nicotine dependence, concluding that the benefit for adult smokers justifies the authorization, provided that the communication is clear and does not promote initiation among non-smokers or young people.
Smoking without fire: the new way to look like a robot 🤖
Now smokers can feel like modern androids, putting nicotine pouches in their mouths without emitting smoke or bothering anyone. Of course, if you see a teenager with a strange smile and a full mouth, it's not that they're chewing gum: it's the new modified risk trend. Because, let's be honest, if the FDA says it's less harmful, young people will surely turn it into the new fashion accessory.